Clinical trial · Observational
Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients
NCT03090386CI-TRIAL-00048570completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Tumor | Brain Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cognitive Surveys | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Cognitive Communication Survey
- timeFrame
- 1 day at time of consent
- description
- Survey is completed at time of consent
Secondary outcomes (2)
- measure
- Cognitive-linguistic Standardized Testing
- timeFrame
- within 3 months of cognitive communication survey
- description
- Standardized testing will be completed
- measure
- Follow-up Survey
- timeFrame
- within 6 months after completion of standardized testing
- description
- Survey will be completed
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 89 Years
Show eligibility criteria text
Inclusion Criteria: * be between18 to 89 years old; * have undergone at least one cycle of a cancer treatment regimen (e.g., chemotherapy, radiotherapy, surgery) * have completed at least one cycle of a cancer treatment regimen within five years of enrollment in the study; * be native speakers of American English; * have obtained a minimum of a high school education; * self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; and * must demonstrate capacity to sign informed consent based on Informed Consent for Research: A Guide to Assessing a Participant's Understanding tool. Exclusion Criteria: * are younger than 18 years old or older than 89 years old; * have not undergone at least one cycle of a cancer treatment regimen following diagnosis (e.g., chemotherapy, radiotherapy, surgery) * have not undergone at least one cycle of a cancer treatment regimen in the five year period prior to enrollment; * are not native speakers of American English; * have not obtained a minimum of a high school education; * do not self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; or * do not demonstrate the capacity to sign informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.